ALLMedicine™ Multiple Sclerosis Center
Research & Reviews 52,997 results
https://doi.org/10.1001/jama.2020.26858
JAMA McGinley MP, Goldschmidt CH et. al.
Feb 23rd, 2021 - Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characterized by inflammatory demyelination with axonal transection. MS affects an estimated 900 000 people in the US. MS typically presents ...
https://doi.org/10.1007/s11255-021-02804-y 10.1186/s12883-019-1582-1 10.1007/s11255-020-02381-6 10.1007/s11910-018-0857-z 10.1007/s00192-019-03993-y 10.1097/JNN.0000000000000367 10.1016/j.sxmr.2018.08.002 10.1007/s13760-020-01323-4 10.6061/clinics/2019/e713 10.1016/j.maturitas.2010.08.004 10.1097/PHM.0000000000001189 10.1212/WNL.33.11.1444 10.1002/nau.20041 10.1007/s00192-006-0223-6 10.1007/BF01186280 10.1016/j.jns.2005.09.009 10.1177/1352458508093619 10.1080/00926230590475206 10.1038/sj.ijir.3901327 10.1016/0002-9378(89)90327-X 10.1177/026921559701100304 10.1016/j.ejogrb.2015.11.039 10.1111/j.1464-410X.2005.05690.x 10.1097/PHM.0000000000000302 10.1016/j.purol.2014.05.003 10.1002/nau.20941 10.1177/0269215520901751 10.1177/1352458514531520 10.1177/0269215518777877 10.1186/s13063-019-3226-6 10.1016/j.jsxm.2019.03.011 10.1177/135245850100700404 10.1111/ene.13010 10.1016/j.msard.2017.01.005 10.1186/s12883-016-0735-8 10.3233/NRE-172200 10.1111/ene.14314
International Urology and Nephrology; Altunan B, Gundogdu AA et. al.
Feb 23rd, 2021 - Multiple sclerosis (MS) is a chronic neuroinflammatory disease of the central nervous system that involves different neurological areas. In addition to lower urinary tract symptoms (LUTS), sexual dysfunction (SD), and psychopathological effects, M...
https://doi.org/10.1016/j.tips.2021.01.004
Trends in Pharmacological Sciences; Hoogendoorn A, Avery TD et. al.
Feb 23rd, 2021 - Fumarates are successfully used for the treatment of psoriasis and multiple sclerosis. Their antioxidative, immunomodulatory, and neuroprotective properties make fumarates attractive therapeutic candidates for other pathologies. The exact working ...
https://doi.org/10.1001/jamaneurol.2020.5520
JAMA Flanagin A, Frey T et. al.
Feb 22nd, 2021 - Pediatric-onset multiple sclerosis (PoMS) is associated with significant cognitive and physical disability. Whether this disability translates into differences in educational achievements and earnings is unknown. To evaluate the association betwee...
https://doi.org/10.1016/j.msard.2021.102836
Multiple Sclerosis and Related Disorders; Cederberg KLJ, Motl RW
Feb 22nd, 2021 - This pilot randomized controlled trial examined the feasibility and efficacy of a physical activity behavior change intervention for improving restless legs syndrome (RLS) severity and secondary sleep outcomes among a sample of adults with multipl...
Guidelines 107 results
https://doi.org/10.1016/j.apmr.2020.10.107
Archives of Physical Medicine and Rehabilitation; Rice LA, Yarnot R et. al.
Jan 19th, 2021 - Fall Prevention for People With Multiple Sclerosis Who Use Wheelchairs and Scooters.|2021|Rice LA,Yarnot R,Peterson EW,Backus D,Sosnoff J,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538221
Neurology Kapoor R, Smith KE et. al.
Jul 17th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...
https://doi.org/10.1016/j.apmr.2020.03.009
Archives of Physical Medicine and Rehabilitation; Siengsukon C, Karahan AY et. al.
May 13th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|
https://www.archives-pmr.org/article/S0003-9993(20)30217-3/pdf
Archives of Physical Medicine & Rehibilitation; Kim Y
Apr 24th, 2020 - To examine the immediate and sustained effects of interventions for changing physical activity behavior in people with multiple sclerosis (MS), and explore factors that might moderate intervention effects on physical activity behavior (e.g., inter...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162735/
Neurol Sci.; Bonavita S
Apr 16th, 2020 - We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quick...
Drugs 371 results see all →
Clinicaltrials.gov 56,163 results
https://doi.org/10.1001/jama.2020.26858
JAMA McGinley MP, Goldschmidt CH et. al.
Feb 23rd, 2021 - Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characterized by inflammatory demyelination with axonal transection. MS affects an estimated 900 000 people in the US. MS typically presents ...
https://doi.org/10.1007/s11255-021-02804-y 10.1186/s12883-019-1582-1 10.1007/s11255-020-02381-6 10.1007/s11910-018-0857-z 10.1007/s00192-019-03993-y 10.1097/JNN.0000000000000367 10.1016/j.sxmr.2018.08.002 10.1007/s13760-020-01323-4 10.6061/clinics/2019/e713 10.1016/j.maturitas.2010.08.004 10.1097/PHM.0000000000001189 10.1212/WNL.33.11.1444 10.1002/nau.20041 10.1007/s00192-006-0223-6 10.1007/BF01186280 10.1016/j.jns.2005.09.009 10.1177/1352458508093619 10.1080/00926230590475206 10.1038/sj.ijir.3901327 10.1016/0002-9378(89)90327-X 10.1177/026921559701100304 10.1016/j.ejogrb.2015.11.039 10.1111/j.1464-410X.2005.05690.x 10.1097/PHM.0000000000000302 10.1016/j.purol.2014.05.003 10.1002/nau.20941 10.1177/0269215520901751 10.1177/1352458514531520 10.1177/0269215518777877 10.1186/s13063-019-3226-6 10.1016/j.jsxm.2019.03.011 10.1177/135245850100700404 10.1111/ene.13010 10.1016/j.msard.2017.01.005 10.1186/s12883-016-0735-8 10.3233/NRE-172200 10.1111/ene.14314
International Urology and Nephrology; Altunan B, Gundogdu AA et. al.
Feb 23rd, 2021 - Multiple sclerosis (MS) is a chronic neuroinflammatory disease of the central nervous system that involves different neurological areas. In addition to lower urinary tract symptoms (LUTS), sexual dysfunction (SD), and psychopathological effects, M...
https://doi.org/10.1016/j.tips.2021.01.004
Trends in Pharmacological Sciences; Hoogendoorn A, Avery TD et. al.
Feb 23rd, 2021 - Fumarates are successfully used for the treatment of psoriasis and multiple sclerosis. Their antioxidative, immunomodulatory, and neuroprotective properties make fumarates attractive therapeutic candidates for other pathologies. The exact working ...
https://doi.org/10.1001/jamaneurol.2020.5520
JAMA Flanagin A, Frey T et. al.
Feb 22nd, 2021 - Pediatric-onset multiple sclerosis (PoMS) is associated with significant cognitive and physical disability. Whether this disability translates into differences in educational achievements and earnings is unknown. To evaluate the association betwee...
https://doi.org/10.1016/j.msard.2021.102836
Multiple Sclerosis and Related Disorders; Cederberg KLJ, Motl RW
Feb 22nd, 2021 - This pilot randomized controlled trial examined the feasibility and efficacy of a physical activity behavior change intervention for improving restless legs syndrome (RLS) severity and secondary sleep outcomes among a sample of adults with multipl...
News 4,915 results
https://reference.medscape.com/viewarticle/917635
Feb 15th, 2021 - Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disease that attacks the myelin of the central nervous system. The most common type is relapsing-remitting multiple sclerosis (RRMS), which accounts for approximately 85% of MS cas...
https://www.medscape.com/viewarticle/945895
Feb 15th, 2021 - Editor's note: The original text has been revised and updated. As Gavin Giovannoni, MBBCh, PhD, an esteemed British multiple sclerosis (MS) expert, set out for his Saturday morning run on Nov. 7, 2020, the world's weighty problems swirled through ...
https://www.medscape.com/viewarticle/945463
Feb 7th, 2021 - Multiple sclerosis (MS) may not pose a higher risk for complications in pregnant women, according to a new study published online Feb. 3 in Neurology Clinical Practice. While pregnancy and childbirth are not regarded as conditions that engender hi...
https://www.medscape.com/viewarticle/945023
Jan 31st, 2021 - The US Food and Drug Administration (FDA) has approved intramuscular (IM) administration of peginterferon β-1a (Plegridy, Biogen) for patients with relapsing forms of multiple sclerosis (MS). "The new IM administration offers people living with re...
https://www.medscape.com/viewarticle/944938
Jan 28th, 2021 - Clinical trials enrolling patients with progressive multiple sclerosis (MS) commonly use the Expanded Disability Status Scale (EDSS), an instrument that looks at impairment across several different functional domains, as a primary outcome measure....